Select how you want to search using keywords

Filter by

Include documents

Document type
Last updated
First published

Search results (10)


The European Medicines Agency (EMA) makes upgrades to this website from time to time, to improve user experience. During these upgrades, the website is unavailable for a short period of time, outside of EMA working hours. This page lists when we are planning the next outage and the main improvements made.

Corporate

These search tips aim to help you use the European Medicines Agency's (EMA) medicine and global sitewide searches more effectively.

CorporateMedicines

The European Medicines Agency (EMA) evaluates an increasing number of new cancer medicines. EMA collaborates with the European medicines regulatory network and international regulators to address the unmet needs of cancer patients. This is meant to advance cancer care and alleviate the burden of cancer in the European Union (EU). It is in line with...

HumanMedicines

A risk minimisation measure (RMM) is intended to reduce adverse reactions of medicines, also called side effects. These measures and the risks they address feature in the product information of medicines authorised in the European Union (EU). Where needed, these measures may also feature in additional resources. The European Medicines Agency (EMA)...

The European Medicines Agency (EMA) publishes information on medicine shortages that affect or are likely to affect more than one European Union (EU) country, where it has assessed the shortage and provided recommendations to patients and healthcare professionals.

HumanRegulatory and procedural guidanceMedicine shortagesMedicines

Members of EMA scientific committees and NCAs assessors who work with scientific advice procedures are invited to attend this webinar to learn how Scientific Explorer can help them in finding relevant information easier and faster.

EventHumanCorporate